Last edition
News about "Agilent"
Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities
Agilent Advanced Therapeutics offers CDMO services spanning oligonucleotides, microbial fermentation, complex chemistry, bioreagents, highly potent APIs, and cell line development, providing integrated end-to-end support from discovery and process development to clinical and commercial manufacturing.
Agilent | 12/03/2026 | By News Bureau
Agilent to Acquire Biocare Medical
Agilent Technologies has agreed to acquire Biocare Medical, expanding its pathology portfolio with complementary antibodies, reagents and instruments. The acquisition is expected to strengthen Agilent’s revenue growth, margin profile and non-instrument revenue mix from the first year.
Agilent | 11/03/2026 | By News Bureau
Agilent Advances Sustainable Science with New India Refurbishment Centre
Agilent Technologies has inaugurated a new refurbishment centre in India, reinforcing its commitment to sustainable science and affordable innovation while enhancing customer engagement through an integrated, green-certified facility that also houses a dedicated education centre.
Agilent | 18/12/2025 | By News Bureau | 258
GenNext and Agilent to Boost High-Value Decision Making in Biopharmaceutical Research
The integration of GenNext's AutoFox Protein Footprinting System with Agilent's 6560 Ion Mobility Quadrupole Time-of-Flight (IM-QTOF) LC/MS System presents an unparalleled approach to detailed protein structure analysis and biomolecular interaction studies.
Agilent | 12/09/2024 | By Aishwarya | 514
Agilent launches gas/liquid chromatography MS products at Future Lab Summit
The innovative design of the equipment will help customers streamline lab analytics and enhance lab productivity with minimal downtime
Agilent | 26/07/2022 | By Sudeep Soparkar | 710
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy